Bingjun Sun
Impact in
- Biomaterials top 0.1%
- Nanoparticle-Based Drug Delivery
- Drug Discovery top 2%
Papers in
- Biomaterials 97
- Nanoparticle-Based Drug Delivery 97
-
- Drug Solubulity and Delivery Systems 10
- Advanced Drug Delivery Systems 3
- Co-authors
- Zhonggui He (123 shared papers)Cong Luo (39 shared papers)Jin Sun (76 shared papers)Xuanbo Zhang (21 shared papers)Shiyi Zuo (31 shared papers)Haotian Zhang (10 shared papers)Qiming Kan (11 shared papers)Qin Chen (6 shared papers)
- Journals
- Journal of Controlled Release (13 papers)Nano Research (8 papers)Nano Letters (8 papers)Nano Today (6 papers)Chinese Chemical Letters (6 papers)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Bingjun Sun
111 papers receiving 5.7k citations
Bingjun Sun's Hit Papers
Peers
Comparison fields: 5 of 89
- Biomaterials 3.4k
- Drug Discovery 19
- Biomedical Engineering 1.8k
- Pharmaceutical Science 327
- Pulmonary and Respiratory Medicine 636
Countries citing papers authored by Bingjun Sun
This map shows the geographic impact of Bingjun Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingjun Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingjun Sun more than expected).
Fields of papers citing papers by Bingjun Sun
This network shows the impact of papers produced by Bingjun Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingjun Sun. The network helps show where Bingjun Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Bingjun Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 129 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 415 | |
| 2 | 2018 | 394 | |
| 3 | 2014 | 323 | |
| 4 | 2019 | 286 | |
| 5 | 2020 | 269 | |
| 6 | Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy Hit paper breakdown → | 2022 | 232 |
| 7 | 2020 | 193 | |
| 8 | 2021 | 186 | |
| 9 | 2016 | 164 | |
| 10 | 2019 | 152 | |
| 11 | 2017 | 150 | |
| 12 | 2019 | 143 | |
| 13 | 2020 | 115 | |
| 14 | 2020 | 107 | |
| 15 | 2021 | 104 | |
| 16 | 2020 | 101 | |
| 17 | 2019 | 98 | |
| 18 | 2022 | 90 | |
| 19 | 2021 | 85 | |
| 20 | 2022 | 83 |
About Bingjun Sun
Bingjun Sun is a scholar working on Biomaterials, Pharmaceutical Science, Biomedical Engineering, Pulmonary and Respiratory Medicine and Immunology, having authored 129 papers that have together received 5.8k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (97 papers), Nanoplatforms for cancer theranostics (28 papers), Drug Solubulity and Delivery Systems (10 papers), Photodynamic Therapy Research Studies (7 papers), Advanced Drug Delivery Systems (3 papers), Ferroptosis and cancer prognosis (3 papers), Immunotherapy and Immune Responses (3 papers) and Protein Interaction Studies and Fluorescence Analysis (2 papers). The work is most often cited by research in Biomaterials (3.4k citations), Drug Discovery (19 citations), Biomedical Engineering (1.8k citations), Pharmaceutical Science (327 citations) and Pulmonary and Respiratory Medicine (636 citations). Bingjun Sun has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Zhonggui He, Cong Luo, Jin Sun, Xuanbo Zhang, Shiyi Zuo, Haotian Zhang, Qiming Kan, Qin Chen, Shenwu Zhang and Yu Han. Their work appears in journals such as Journal of Controlled Release, Nano Research, Nano Letters, Nano Today and Chinese Chemical Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.